IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.652
EU - Europa 3.921
AS - Asia 3.668
SA - Sud America 699
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 13.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.530
SG - Singapore 1.512
CN - Cina 1.112
IT - Italia 729
IE - Irlanda 675
BR - Brasile 571
SE - Svezia 528
UA - Ucraina 514
TR - Turchia 362
DE - Germania 355
GB - Regno Unito 342
FR - Francia 242
VN - Vietnam 230
FI - Finlandia 189
IN - India 160
RU - Federazione Russa 122
KR - Corea 94
CA - Canada 67
AR - Argentina 66
HK - Hong Kong 54
AT - Austria 44
NL - Olanda 34
MX - Messico 32
PL - Polonia 31
BD - Bangladesh 24
ID - Indonesia 23
EC - Ecuador 21
ES - Italia 21
BE - Belgio 18
CZ - Repubblica Ceca 17
JP - Giappone 17
RO - Romania 14
ZA - Sudafrica 14
IQ - Iraq 13
CO - Colombia 11
LT - Lituania 11
CH - Svizzera 9
KE - Kenya 9
PY - Paraguay 9
CL - Cile 6
MA - Marocco 6
PS - Palestinian Territory 6
UY - Uruguay 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
EG - Egitto 5
IL - Israele 5
PH - Filippine 5
PK - Pakistan 5
TW - Taiwan 5
UZ - Uzbekistan 5
VE - Venezuela 5
EU - Europa 4
HR - Croazia 4
JO - Giordania 4
PE - Perù 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BG - Bulgaria 3
EE - Estonia 3
JM - Giamaica 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
DK - Danimarca 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
KZ - Kazakistan 2
MY - Malesia 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
NI - Nicaragua 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
Totale 13.988
Salva come PNG Salva come JPEG
Città #
Singapore 1.130
Chandler 780
Jacksonville 696
Dublin 658
Dallas 536
Ashburn 334
Princeton 318
Beijing 288
Southend 244
Nanjing 215
Izmir 195
The Dalles 166
Santa Clara 148
Altamura 141
Los Angeles 141
Munich 126
Chieti 111
Dearborn 108
Wilmington 104
Cambridge 97
Ann Arbor 87
New York 84
Tongling 82
Boardman 76
Ho Chi Minh City 72
Redondo Beach 69
Buffalo 66
São Paulo 66
Nanchang 65
Pescara 58
Hong Kong 53
Helsinki 45
Hanoi 44
Nuremberg 38
Shenyang 37
Rome 36
Turku 34
Brooklyn 33
Seattle 33
Pune 32
Denver 30
Dong Ket 30
Tianjin 28
Warsaw 28
Washington 28
Hebei 27
Hefei 25
Jiaxing 25
Kunming 24
Toronto 24
Woodbridge 24
Rio de Janeiro 23
Milan 22
Montreal 21
Atlanta 20
Changsha 20
Chicago 20
Hangzhou 20
Mexico City 19
Frankfurt am Main 18
Brussels 17
London 17
Tokyo 17
Grevenbroich 16
Norwalk 16
Phoenix 16
San Francisco 16
Stockholm 16
Chennai 14
Houston 14
Jinan 14
Orem 14
Salvador 14
Vienna 14
Augusta 13
Boston 13
Changchun 13
Espoo 13
Moscow 13
Brasília 12
Curitiba 12
Brno 11
Da Nang 10
Jakarta 10
Poplar 10
Falls Church 9
Guarulhos 9
Haiphong 9
Johannesburg 9
Lappeenranta 9
Porto Alegre 9
Guangzhou 8
Lanzhou 8
Nairobi 8
Orange 8
San Mateo 8
San Vito Chietino 8
Seoul 8
Tappahannock 8
Ankara 7
Totale 8.592
Salva come PNG Salva come JPEG
Nome #
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 150
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 150
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 148
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 143
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 142
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 139
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 135
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 131
Metabolic modifications in HIV-infected women 129
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 128
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 127
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 127
Acute urinary retention due to HSV-1: a case report 126
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 124
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 123
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 123
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 121
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 120
Canakinumab in a subgroup of patients with COVID-19 119
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 118
Relevance of plant lectins in human cell biology and immunology 117
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 116
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 114
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 114
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 114
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 112
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 111
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 111
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 110
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 110
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 110
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 109
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 108
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 108
Inguinal lymphadenopathy due to Bartonella henselae 106
Antiretroviral therapy management and rationalisation of available resources 106
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 106
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 105
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 105
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 105
Is the rate of virological failure to cART continuing to decline in recent calendar years? 105
Normal breathing releases SARS-CoV-2 into the air 105
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 104
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 104
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 103
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 103
IL-1beta induces alkaline phosphatase in human phagocytes 102
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 100
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 99
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 99
Periodontitis and cytokine patterns in HIV positive patients 98
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 97
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 97
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 97
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 96
Proteinuria in an African HIV-infected patient: effects of telmisartan. 96
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 95
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 94
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 92
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 92
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 92
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 92
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 92
High dose of erythropoietin in management of interferon/ribavirin induced anemia 91
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 91
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study. 91
Hypertension in HIV: Management and Treatment 91
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 90
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 90
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 89
Interleukin-31: a new cytokine involved in inflammation of the skin 89
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 89
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 87
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 87
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 87
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 87
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 86
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 86
Associations between immune depression and cardiovascular events in HIV infection. 86
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 86
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 85
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. 85
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 85
Infected atrial mixoma: a rare cause of fever 84
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 84
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 84
Pidotimod and Immunological Activation in Individuals Infected with HIV 84
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 83
Parameters associated with diagnosis of COVID-19 in emergency department 83
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 82
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 82
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 82
IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances 81
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 81
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 81
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals 81
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. 79
Ruolo delle citochine nella patogenesi delle malattie infettive 78
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. 78
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 78
Totale 10.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021487 0 0 0 0 0 170 33 24 57 82 52 69
2021/2022773 27 24 11 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/20252.970 187 528 383 112 60 134 97 183 267 209 336 474
2025/20263.174 470 251 876 897 590 90 0 0 0 0 0 0
Totale 14.780